Your browser doesn't support javascript.
loading
Practical guidelines of the EOTTD for pathological and genetic diagnosis of hydatidiform moles.
Bartosch, Carla; Nadal, Alfons; Braga, Ana C; Salerno, Angela; Rougemont, Anne-Laure; Van Rompuy, Anne-Sophie; Fitzgerald, Brendan; Joyce, Caroline; Allias, Fabienne; Maher, Geoffrey J; Turowski, Gitta; Tille, Jean-Christophe; Alsibai, Kinan Drak; Van de Vijver, Koen; McMahon, Lesley; Sunde, Lone; Pyzlak, Michal; Downey, Paul; Wessman, Sandra; Patrier, Sophie; Kaur, Baljeet; Fisher, Rosemary.
  • Bartosch C; Department of Pathology, Cancer Biology & Epigenetics Group, Research Center of IPO Porto (CI-IPOP) / RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC) and Centro Hospitalar Universitário S. Jo
  • Nadal A; Department of Pathology, Clínic Barcelona, Department of Basic Clinical Practice, Universitat de Barcelona, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.
  • Braga AC; Department of Pathology, University Hospital Centre of São João (CHUSJ) / Faculty of Medicine - University of Porto (FMUP) / School of Health (ESS) - Polytechnic Institute of Porto (P. PORTO), Alameda Prof. Hernâni Monteiro, 4200-319, Porto, Portugal.
  • Salerno A; Anatomia Patologica, Ospedale Maggiore AUSL Bologna, Bologna, Italy.
  • Rougemont AL; Division of Clinical Pathology, Geneva University Hospital, Geneva, Switzerland.
  • Van Rompuy AS; Department of Pathology, University Hospitals Leuven, Louvain, Belgium.
  • Fitzgerald B; Department of Pathology, Cork University Hospital, Cork, Ireland.
  • Joyce C; Department of Clinical Biochemistry, Cork University Hospital, Ireland/ Pregnancy Loss Research Group, Department of Obstetrics & Gynaecology, University College Cork, Cork, Ireland.
  • Allias F; Department of Pathology, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre Bénite, France.
  • Maher GJ; Trophoblastic Tumour Screening & Treatment Centre, Imperial College NHS Trust, Charing Cross Hospital, Fulham Palace Road, London, W6 8RF, UK.
  • Turowski G; Department of Pathology, Oslo University Hospital, INNPATH Tirolkliniken, Innsbruck, Austria.
  • Tille JC; Division of Clinical Pathology, Geneva University Hospital, Geneva, Switzerland.
  • Alsibai KD; Department of Pathology and Center of Biological Resources (CRB Amazonie), Cayenne Hospital Center Andrée Rosemon, 97306, Cayenne, France.
  • Van de Vijver K; Department of Pathology, Ghent University Hospital, Ghent, Belgium.
  • McMahon L; Scottish Hydatidiform Mole Follow-Up Service, Ninewells Hospital and Medical School, Dundee, Scotland.
  • Sunde L; Department of Clinical Genetics, Aalborg University Hospital, Denmark/Department of Biomedicine, Aarhus University, Aalborg, Aarhus, Denmark.
  • Pyzlak M; Department of Pathology, Institute of Mother and Child, Warsaw, Poland.
  • Downey P; Department of Pathology, National Maternity Hospital, Dublin, D02YH21, Ireland.
  • Wessman S; Department of Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden.
  • Patrier S; Department of Pathology, Rouen University Hospital, Rouen, France.
  • Kaur B; Department of Pathology, North West London Pathology, Imperial College NHS Trust, Fulham Palace Road, London, W6 8RF, UK.
  • Fisher R; Department of Surgery and Cancer, Imperial College London, Charing Cross Hospital. Fulham Palace Road, London, W6 8RF, UK.
Virchows Arch ; 484(3): 401-422, 2024 Mar.
Article en En | MEDLINE | ID: mdl-37857997
Hydatidiform moles are rare and thus most pathologists and geneticists have little experience with their diagnosis. It is important to promptly and correctly identify hydatidiform moles given that they are premalignant disorders associated with a risk of persistent gestational trophoblastic disease and gestational trophoblastic neoplasia. Improvement in diagnosis can be achieved with uniformization of diagnostic criteria and establishment of algorithms. To this aim, the Pathology and Genetics Working Party of the European Organisation for Treatment of Trophoblastic Diseases has developed guidelines that describe the pathological criteria and ancillary techniques that can be used in the differential diagnosis of hydatidiform moles. These guidelines are based on the best available evidence in the literature, professional experience and consensus of the experts' group involved in its development.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Uterinas / Mola Hidatiforme / Enfermedad Trofoblástica Gestacional Límite: Female / Humans / Pregnancy Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Uterinas / Mola Hidatiforme / Enfermedad Trofoblástica Gestacional Límite: Female / Humans / Pregnancy Idioma: En Año: 2024 Tipo del documento: Article